| Carrying amounts of major classes of assets and liabilities classified as held for sale |
The following table presents the pre-tax gain recognized during the three and six months ended June 30, 2025 associated with the dispositions described above (in thousands): | | | | | | | Gross sales proceeds | $ | 122,336 | | | Net assets sold | (90,111) | | | Total | $ | 32,225 | |
The carrying value of the net assets sold at their respective closing dates associated with the dispositions described above were as follows (in thousands): | | | | | | | Cash | $ | 5,161 | | | Accounts receivable | 12,667 | | | Inventory | 1,770 | | | Prepaid and other current assets | 1,142 | | | Equipment and other fixed assets, net | 909 | | | Operating lease right-of-use assets | 776 | | | Goodwill | 80,943 | | | Identifiable intangible assets, net | 2,435 | | | Other assets | 11 | | | Accounts payable and accrued expenses | (13,451) | | | Operating lease liabilities | (802) | | | Other liabilities | (1,450) | | | Total | $ | 90,111 | |
The following table summarizes the major classes of assets and liabilities classified as held for sale (in thousands): | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Assets | | | | | Inventory | $ | 34,219 | | | $ | 36,354 | | | Equipment and other fixed assets, net | 6,413 | | | 6,763 | | | Goodwill | 83,801 | | | 83,801 | | | Identifiable intangible assets, net | 43,665 | | | 49,347 | | | Total assets held for sale - discontinued operations | $ | 168,098 | | | $ | 176,265 | | | Liabilities | | | | | Contract liabilities | $ | 560 | | | $ | 504 | | | Total liabilities held for sale - discontinued operations | $ | 560 | | | $ | 504 | |
The following table summarizes the results of discontinued operations (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Net revenue | $ | 154,440 | | | $ | 143,272 | | | $ | 294,365 | | | $ | 276,607 | | | Costs and expenses: | | | | | | | | | Cost of net revenue | 132,619 | | | 124,402 | | | 256,675 | | | 242,877 | | | General and administrative expenses | 2,378 | | | 2,173 | | | 4,402 | | | 4,132 | | | Depreciation and amortization, excluding patient equipment depreciation | 2,893 | | | 3,139 | | | 5,828 | | | 6,281 | | | Income from discontinued operations before income taxes | $ | 16,550 | | | $ | 13,558 | | | $ | 27,460 | | | $ | 23,317 | | | Income tax expense | 5,163 | | | 3,111 | | | 7,096 | | | 6,447 | | | Net income from discontinued operations, net of tax | $ | 11,387 | | | $ | 10,447 | | | $ | 20,364 | | | $ | 16,870 | |
The following table provides significant non-cash operating and investing cash flow information for the Company's discontinued operations: | | | | | | | | | | | | | Six Months Ended June 30, | | 2026 | | 2025 | | Operating activities: | | | | | Depreciation and amortization, including patient equipment depreciation | $ | 11,083 | | | $ | 10,839 | | | Reduction in the carrying amount of operating lease right-of-use assets | 267 | | | 450 | | | Equity-based compensation | 325 | | | 225 | | | Investing activities: | | | | | Purchases of equipment and other fixed assets | $ | 5,016 | | | $ | 4,152 | |
|